IIM
LLY icon

Illumine Investment Management’s Eli Lilly LLY Stock Holding History

Illumine Investment Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-600
Closed -$613K – 71
2026
Q1 		$552K Buy
600
+20
+3% +$20.3K 0.42% 73
2025
Q4 		$623K Hold
580
– – 0.45% 66
2025
Q3 		$443K Buy
580
+30
+5% +$22.3K 0.32% 79
2025
Q2 		$429K Hold
550
– – 0.34% 77
2025
Q1 		$454K Hold
550
– – 0.37% 78
2024
Q4 		$425K Buy
+550
New +$455K 0.35% 73

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Illumine Investment Management's LLY Position: Q2 2026 in Review

Illumine Investment Management sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 600 shares — an estimated $613K sold.

Illumine Investment Management first reported a position in LLY in Q4 2024 and held it in 6 quarters. The position peaked at $623K in Q4 2025. 4,645 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Illumine Investment Management reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
  • Illumine Investment Management sold 600 Eli Lilly shares in Q2 2026, an estimated $613K.
  • Illumine Investment Management first reported a position in Eli Lilly in Q4 2024 and held it in 6 quarters.
  • Illumine Investment Management's Eli Lilly position peaked at $623K in Q4 2025.
  • 4,645 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Illumine Investment Management's 13F filing for Q2 2026, filed 29 Jul 2026.